Nelaj, E., Kecaj, I., Feracaku, J., Xhixhabesi, K. and Tase, M. 2024. Benefits of SGLT2 inhibitors on renal and cardiovascular protection, in diabetic patients. South Eastern European Journal of Public Health. (Aug. 2024), 200–206. DOI:https://doi.org/10.70135/seejph.vi.689.